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A randomized study was conducted to test the efficacy of Moringa powder on iron 
status and weight gain in women. In an open-labelled randomized trial, 82 moderately 
anaemic, lactating women, aged 26.7± 6.5 years, received a weekly dose of either 
100g of Moringa powder(Moringa group) or 120 mg iron sulphate with 0.5 mg folic 
acid (Control group). Data from 64 women (33 from Moringa group and 31 from 
Control group) were analyzed. Baseline parameters, socio-economic, anthropometry, 
haematology, plasma ferritin, and acute phase proteins were comparable in both 
groups. Low plasma ferritin (< 12 μg/l) indicating iron deficiency was found in 13 
and 14 women from the Moringa and Control groups, respectively. After 3 months of 
treatment, mean haemoglobin concentrations significantly increased in both groups 
(p<0.001) but iron stores were unchanged in the Moringa group while they 
significantly increased in the Control group indicating that consumption of Moringa 
leaves failed to restore iron stores in anaemic subjects. A slight improvement was 
observed in the prevalence of anaemia in both groups but anaemia still persisted due 
to other reasons than iron deficiency anaemia. None of the groups gained weight 
during the 3 months. However, the average weight lost was less important in the 
Moringa group (-0.8 ± 2.1 kg) compared to the control group (-1.2± 2.3 kg) but the 
difference was not significant (p=0.45).The amount of digestible protein in the 
powder could suggest that the consumption of Moringa was beneficial to the rural 
women by preventing weight loss during the rainy season. Micronutrient status 
improvement of vulnerable people in developing countries like Senegal should 
combine diet-based strategies through production and consumption of animal derived 
food, vegetable, fruits and food fortification program. However, Moringa Oleifera is 
one example of local food that can be used in nutritional intervention program, but its 
use needs additional rigorous clinical trials to confirm its nutritional benefits. 
 










Moringa Oleifera leaves have been widely consumed by rural families in Senegal for 
a long time. According to the book “the miracle tree”, the dried and powdered leaves 
can prevent malnutrition and restore iron reserves because of its high content of 
protein and micronutrients including iron. However, scientific studies were lacking to 
substantiate these statements. Outside of anecdotal evidence of benefits from Moringa 
Oleifera, no clinical trials or randomized studies in human have been completed to 
show the efficacy of Moringa Oleifera leaves consumption on iron deficiency 
anaemia or malnutrition treatment. This was recently related by Thurber et al. [1]. 
 
Anaemia associated with malnutrition remains one of the most significant public 
health problems in developing countries. In Senegal, according to the Demographic 
and Health Survey, the prevalence of malnutrition in women (BMI < 18.5 kg/m²) 
increased from 15% in 1993 [2] to 18% in 2005 [3]and,59% of Senegalese women 
were anaemic in 2005. This prevalence was 34.1%for mild (10.0-10.9g/dl), 8.7% for 
moderate (7.0-9.9 g/dl) and 0.9% for severe anaemic women in Ziguinchor area [3]. 
Because strategies to prevent malnutrition and anaemia are expensive for rural 
populations in developing countries, local approaches are commonly used. Thus, 
edible plants like Moringa Oleifera leaves are used to fight this burden. Belonging to 
the genus Moringaceae, Moringa Oleifera is a well known ancient plant recently 
acknowledged as a multi-purpose tree with a tremendous variety of potential uses. In 
Senegal, the plant is called ‘Nebeday’ (never die)due to its drought-resistance and 
rapid growth. The Moringa tree grows everywhere in Senegal and the leaves can be 
found in both rural and urban markets. Senegalese people use its leaves in different 
ways: in the form of dried leaf powder which is added to many porridges or in the 
preparation of a sauce called “Mbumm”, which is eaten with maize or millet. Apart 
from medicinal properties, nutritional properties are also attributed to Moringa leaves 
due to its high concentration of iron, protein, calcium, copper, various vitamins and 
essential amino acids [4]. According to the book “Moringa Oleifera: the miracle tree”, 
Moringa dry leaves added on a regular basis to an individual’s usual diet, could 
prevent or cure anaemia and malnutrition [5]. However, no scientific study has been 
undertaken to evaluate the efficacy of Moringa leaves on impacting malnutrition and 
iron deficiency anaemia prevention or recovery. The aim of this study was to evaluate 
the effect of daily consumption of Moringa dried leaf powder on nutritional and iron 
status of anaemic lactating women in Senegal. 
 
SUBJECTS AND METHODS 
 
Study area and subjects.  
The study was conducted in a district of Ziguinchor (Region of Ziguinchor) in south-
western Senegal between July and October 2001 during the rainy season. Another 
project, ‘Projet de Nutrition Communautaire’ (PNC), one of whose objectives was to 
improve nutritional status of lactating women, was implemented in the same area and 
its facilities (including 15 PNC centres in the area) were used for this study. Thus, the 
subjects of the study were selected from among PNC recruits. All lactating women 
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their nutritional monitoring card (women were included if they were anaemic but not 
severely anaemic). A sample size was calculated with a power of 80% and a 5% 
significance level. To achieve a difference in haemoglobin concentration of 6±8 g/L 
between the beginning and the end of supplementation, a minimum of 28 women 
were required in each group [6].The study was approved by the Ethics Committee of 
Dakar University and by the regional hospital of Ziguinchor and was conducted 
according to the guidelines set out in the Helsinki declaration. Before enrolment, a 
full explanation of the study was given to the mothers, and verbal informed consent 
was obtained from 94 eligible women. A selection of anaemic women was carried out 
by capillary blood screening according to WHO criteria for the definition of anaemia, 
which is haemoglobin concentration <120g/L [7]. Women with severe anaemia 
(haemoglobin <70g/L) were excluded from the study and referred to the hospital for 
appropriate clinical care. A total of 82 anaemic women were randomly assigned to 1 
of 2 groups, Moringa (n=41) or Control (n=41), using a computer-generated list. 
 
Intervention 
Women received either Moringa dried leaf powder or iron tablets with both ferrous 
sulphate and folic acid during 3 months. Because of the different colour and 
consistency of the supplements, the study was open trial. Women in the Moringa 
group received 100g of dried leaf powder per week which represented the usual 
supplementation dose they received at local health centres. The powder which was 
supplied by AGADA/CHURCH WORLD SERVICE, an NGO in Ziguinchor area, 
was prepared by crushing the leaves which were dried in the traditional way, out of 
direct sunlight. The weekly dose was consumed three times daily at mealtimes by 
adding it to sauces or to porridges just before serving them. Regular home visits 
(3/week) were made by PNC fieldworkers to check actual Moringa powder 
consumption. Control group women received 2 ferrous sulfate/folic acid tablets 
weekly. Each tablet was equivalent to 130 mg of elemental iron and 0.5mg of folic 
acid in accordance with recommended dosages for weekly treatment of anaemia at the 
beginning of the study [6]. The iron supplement was administered at PNC centres or 
at home if the subject missed her appointment. 
 
Socioeconomic and diet surveys 
Socioeconomic status and food consumption were assessed by trained fieldworkers 
using a questionnaire. The socioeconomic questionnaire included individual 
characteristics of the mother, occupation and education, information on infant feeding 
practices, as well as frequency consumption of foods rich in iron, compliance, 
utilisation of the powder and any unpleasant effect encountered. 
 
Anthropometric measurements 
Bodyweight and height were measured at baseline and at 1, 2 and 3 months of the 
study. Body weight was measured to the nearest 100g by an electronic scale 
(TANITA BWB-800, Tanita Corporation, Tokyo, Japan).Height was measured to the 
nearest millimetre by using a wall-mounted stadiometer. Body mass index (BMI) was 
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Haematological and Biochemical measurements 
Blood samples (5ml) were drawn at baseline and at the end of the study (3 months) by 
venipuncture from all women in EDTA tubes. The samples were transported in a 
portable ice box to the laboratory within 3h. After the haematological indices were 
assayed, the remaining blood was immediately centrifuged at 1735g (4000 rpm, 
Sigma 3K20; B. Braun, Laboratory Centrifuges GmbH, 3360 Osterode/Harz, 
Germany) for 5min at 4°C. The plasma was divided in 2 aliquots and stored at -20°C 
until analysis.  
 
At baseline, whole blood, complete blood count, haemoglobin (Hb), hematocrit (Hct) 
and red cell indices were determined using a counter (model Sysmex K-1000, 
France). Anaemia was classified as microcytic if Hb<120g/Land Mean Corpuscular 
Volume (MCV)<80fl; hypochromic if Hb<120g/Land Mean Corpuscular 
haemoglobin (MCH)<27pg [7]. For parasite counts, thin and thick blood films were 
stained with 10% Giemsa and examined for the presence of malaria parasites. Parasite 
density was determined on the basis of the number of parasites per 200 white blood 
cells (WBC) on a thick blood film assuming a total WBC count of 8000/µl. The 
following formula was used:  
 
Parasites/µl = (Number of parasites found after counted 200 WBC ×8000) / 
200.Sickle cell disease was also determined by microscopic observation of red cells 
containing sickle haemoglobin under a cover slip by suspending the cells in a droplet 
of a 2% solution of sodium metabisulfite (reducing agent) which deprived red cells of 
oxygen. 
 
Iron status was defined by haemoglobin, hematocrit, MCV, MCH and ferritin 
parameters. Plasma ferritin was measured using an automated quantitative test on a 
MINI VIDAS analyser (Biomerieux SA, France). The assay principle combines a 
one-step enzyme immunoassay sandwich method with a final fluorescent detection 
(ELFA: Enzyme Linked Fluorescence Assay). A plasma ferritin value, less than 
12µg/L indicates a depletion of body iron stores [6]. To rule out inflammation, which 
is known to increase plasma ferritin concentration, C-reactive protein (CRP) and α-1 
acid glycoprotein (AGP) were measured by immunoturbidimetry assay using Dako 
Diagnostic reagents (Dako A/S, Glostrup, Denmark). Both determinations were done 
with a Cobas Mira Plus (Roche, France).Inflammation and/or infection states were 
defined by AGP concentration>1.20g/Land/or detectable CRP>5mg/L [8]. 
 
Statistical analysis 
The data were analyzed using Excel 2000 and SYSTAT 8.0 (SPSS Inc., 1998, 
Chicago IL, USA).The results are expressed as means ±SD or percentages. 
Comparison between the groups was done using the Mann-Whitney test. The 
Wilcoxon test was used for matched groups’ comparison and the chi-square (χ²) test 
was used for proportions. Because plasma ferritin had a skewed distribution, log 
transformation was applied to normalize the distribution before statistical analysis. 
The relationships between quantitative variables were analysed by Pearson’s linear 











During the intervention phase (3 months), full data were obtained from 33 women in 
the Moringa group, and 31 in the Control group. Data for the remaining 18women 
were missing for the following reasons: 6 women dropped out during the second week 
of supplementation (3 in the Moringa group and 3 in the Control group); 7 women 
were absent during the fifth week of supplementation (3 in the Moringa group and 4 
in the Control group) and 5 were not present at the last blood sampling (2 in the 























Figure 1: Study design 
94 lactating women 
assessed for eligibility 
Non anaemic women 
Hb≥ 12 g/dl (n= 12) 
Anaemic randomly assigned women 
Hb < 12g/dL 
(n=82) 
Moringa group (n=41) 
Treatment received: 100g of 
moringa powder/week 
Control group (n=41)  
Treatment received: 130mg of iron 
sulfate+0.5mg folic acid /week 
Lost to follow-up (n=8) 
3 dropped out during the 2nd 
week of supplementation 
3 dropped out during the 5th 
week 
2 not present at the last 
blood sampling 
Lost to follow-up (n=10) 
3 dropped out during the 2nd 
week of supplementation 
4 dropped out during the 5th 
week 
3 not present at the last 
blood sampling 
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Baseline characteristics 
Anthropometric and biological parameters of women in the Moringa and Control 
groups at baseline were summarised in Table 1. No significant difference was found 
between the 2 groups. 
 
Likewise, both groups were not significantly different for iron status and acute phase 
proteins. 39% and 32% of women in the Moringa and Control groups, respectively, 
had haematocrits<36%. Microcytic anaemia was found in three women in the 
Moringa group and hypochromic anaemia was found in 64% and 71% of the Moringa 
and Control groups, respectively. Low plasma ferritin concentrations (< 12 µg/L) 
were also found in Moringa (n=13)and Control group (n=14)at baseline. 
 
Plasmodium falciparum test was positive in fifteen and nine women in the Moringa 
and the Control groups, respectively. The sickle cell trait was carried by 3 women in 
the Moringa and 4 women in the Control group. Differences in these baseline 
characteristics between the two groups were not statistically significant. 
 
Socioeconomic status and treatment compliance 
Socioeconomic status was comparable for both groups on marital status, education 
level, and husband’s occupation. A significant difference has been found between the 
groups for women’s occupation (p= 0.035). In the Control group, almost all of women 
had no jobs while 6 in the Moringa group had income generation activities and 2 were 
salaried. 
 
Compliance to treatment was high as 57% of the women used a tablespoon of 
Moringa per meal and 43% used a teaspoon per meal. The powder was well accepted, 
but at the beginning of the supplementation, 1 case of vomiting and 3 cases of 
diarrhoea were recorded. Most of the women (84% and 87% in the Moringa and 
Control groups, respectively) claimed to take iron tablets before the study period, 26% 
and 36% of them had taken iron tablets during their pregnancy and after delivery.  
 
Effects of supplementation on nutritional and iron status 
At the end of the supplementation period (3 months), lactating women’s weight was 
not significantly different between the groups. Women did not gain weight during the 
treatment period. The weight deficit was less important in the Moringa group (-0.8 ± 
2.1 kg; p<0.05) compared to the control group (-1.2 ± 2.3 kg; p<0.01). The mean BMI 
indicated that in the Moringa group BMI was stable in contrast to the Control group in 
which there was a significant decrease (p<0.01) at 3 months (Table 2). 
 
During the supplementation period, mean haemoglobin concentrations increased 
significantly in both groups (p<0.001), but this increment was higher in the Control 
group (p<0.05) than in the Moringa group. Thirty two percent of the women (n=10) in 
the Control group improved their Hb concentration (Hb ≥120 g/L) compared to 21% 
(n=7) in the Moringa group. Haematocrit levels also increased significantly in the 
Control group (p<0.01) but not in the Moringa group and the 2 groups were 
significantly different at 3mo (p<0.01). In the Control group, haematocrit levels 
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45% of women in the Moringa group.MCV did not change, MCH significantly 
increased (p<0.001) in both groups; however,39% and 41% of the women in the 
Moringa and Control groups, respectively, still had MCH <27pg at the end of the 
study. At 3months, plasma ferritin in the Control group was significantly 
higher(p<0.01) compared to the Moringa group. The mean value increased 
significantly during the intervention period (p<0.001) in the Control group unlike the 
Moringa group. Only two women(6%) had low plasma ferritin concentration in the 
Control group versus 13 women (39%)in the Moringa group. Inflammatory or 
infection status was not different at the end of the study between groups: 3women in 




Low iron bioavailability in Senegalese foods and typical diets of West African 
populations is known as one of the main causes of iron deficiency [9, 10]. Moreover, 
iron requirements for lactating women are more important than women of 
reproductive age as they usually have low iron stores due to high requirements during 
pregnancy, and blood loss during delivery and the post-partum period [11]. Also, 
women of reproductive age compliance with iron supplements were low during 
pregnancy and the post-partum periods. In our study, 88% of anaemic women claimed 
to have taken iron tablets but the number of tablets taken and the length of treatment 
were unknown. 
 
Although haemoglobin concentrations were significantly increased in the Moringa 
and the Control groups (p<0.001) at the end of 3 months supplementation, 68% of 
women in the Control group and 79% in the Moringa group had haemoglobin 
concentrations less than 120g/L. In our study, presence of intestinal parasites was not 
determined but several studies carried out in rural and urban areas in Senegal indicate 
a prevalence of 60% of intestinal parasitosis in the Ziguinchor region [12].The 
presence of malaria parasitemia and blood loss caused by other parasitosis such as 
schistosomia and ankylosotomia could explain this high rate of anaemia. Infections by 
Plasmodium vivax, Ascarislumbricoides and Trichurustrichiura have been identified 
as important causes of anaemia and iron deficiency in pregnant women in Nepal [13]. 
Since acute infection was not prevalent, intestinal parasitosis could likely explain the 
persistence of anaemia after 3 months of treatment. It is also possible that these 
women were deficient in other nutrients (vitamin B12) that could limit haematological 
responses. More research is needed to understand which nutrients are limiting. 
 
Plasma ferritin was also found to be significantly increased in the Control group and 
48 % of women had improved their iron stores. This increase in plasma ferritin is 
consistent with findings of Imelda et al.[14] in female Indonesian adolescents 
supplemented with the same weekly dose of iron for 3 months. Several current studies 
show that weekly iron supplementation can decrease anaemia prevalence in pre-
school children, adolescents and pregnant women [6, 15, 16]. Plasma ferritin did not 
change in the Moringa group during the intervention. This result was not surprising 
but highlighted the low iron bioavailability in plant food as noted by several authors 
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In a previous study, Moringa leaf powder’s nutrient analysis, protein digestibility and 
iron bioavailability showed that the leaves contain important quantities of several 
minerals as well as protein [19].The present study confirmed that despite the high 
amount of iron in the Moringa powder, the iron bioavailability was low (2.2%). 
Therefore, the amount of bio-available iron consumed per day in the meals mixed 
with Moringa powder was probably very low and unable to cover daily requirements.  
 
As demonstrated by several authors, vegetable iron is non-heme iron with low 
absorption. In iron deficient rats fed with Moringa leaf powder, Ndong et al. [20] 
showed that Moringa did not improve haemoglobin or iron content of liver. Moreover, 
the food consumption questionnaire indicated that meat consumption was low in the 
study population. It is well established that muscle tissue like red meat is a strong 
enhancer of non-heme iron absorption, better than fish, poultry, ascorbic acid, retinol 
and carotenes [18]. Analysis of the nutritional value of Moringa Oleifera showed that 
Moringa powder contained polyphenols, which are known to have an inhibitory effect 
on iron bio-availability[19]. This inhibitory effect is related to phenolic structures 
associated with gallocyl and catechol groups which chelate iron and form non-bio-
available polyphenol-iron complexes [20, 21]. Nevertheless, slight improvements in 
haemoglobin concentration in the Moringa group could be explained by an increase in 
protein intake or by the presence of ascorbic acid and beta-carotene in Moringa leaf 
powder, which are also non-heme-iron enhancers [5, 18, 22]. The Moringa protein 
digestion products (amino acids) could also contribute to erythropoietin activity by 
providing amino acids to porphyrin, globin and transferrin synthesis [23]. Serum 
ferritin and other blood parameters of iron status were insensitive to dietary treatment 
according to Hunt et al. [24].This could be explained by long-term adaptation in iron 
absorption to maintain iron stores. 
 
At the end of the treatment, women in the Control group had lost more weight than 
those in the Moringa group. The Moringa group’s BMI remained stable during the 
study while the Control group’s BMI decreased significantly. Less weight loss in the 
Moringa group might be related to the high content of proteins in Moringa dried 
leaves. 
 
In summary, contrary to the hypothesis of the book “Moringa Oleifera: the miracle 
tree”, daily consumption of Moringa Oleifera dried leaf powder did not improve iron 
status in anaemic lactating women but prevented significant weight loss during the 
rainy season. Weekly supplementation with iron and folic acid is effective for 
correcting iron deficiency anaemia but not maintaining body weight. Moringa leaf 
powder contains iron but its bioavailability was low and could not cover iron 
requirements in the lactating women. But its wealth of proteins and other potential 
health benefit effect might be a great complement to the Senegalese diet 
[20].Intervention programs to improve micronutrient status and recovery of 
vulnerable people should combine diet-based strategies through production and 
consumption of animal derived food, vegetable, fruits and food fortification program. 
The challenge is that several national iron/folic acid fortification programs undertaken 
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Table 1: Baseline anthropometric measurements and biological parameters of 
subjects 
 
 Moringa group (n=33) Control group3 (n=31) 
Age (y) 26 ± 7± 7,3 27 ± 6 
Weight (kg) 58.9 ± 10.7 58.8 ± 10.4 
BMI (kg/m2) 23.2 ± 4.2 22.8± 3.6 
Hb (g/L) 105 ± 8 105 ± 9 
Hct (%) 36.0 ± 2.5 36.5 ± 2.4 
MCV (fl) 88.2 ± 7.2 89.0 ± 5.8 
MCH (pg) 25.7 ± 2.7 25.8 ± 2.2 
Ferritin1 (µg/L) 1.2 ± 0.4 1.1 ± 0.4 
AGP (g/L) 0.7 ± 1.2 0.7 ± 0.2 
2CRP 3 2 
 
BMI: Body Mass Index; Hb: Haemoglobin; Hct: Hematocrit; MCV: Mean Corpuscular 
Volume;  
 
MCH: Mean Corpuscular Haemoglobin; AGP: α-1 acid glycoprotein; CRP: C-reactive protein 
Values are mean ± SD; n: number of subjects 
 
1 Log concentration of ferritin 
2 Number of subjects who had CRP value > 5 mg/l 
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Table 2: Body mass index and haematological status of women at baseline and 3 
months  
 
 Moringa group (n=33) Control group
4 (n=31) 
 baseline 3 mo p3 baseline 3 mo p3 
Weight (kg) 58.9±10.7 58.1±10.8 0.031 58.8±10.4 57.5±10.9 0.004 
BMI 23.2 ± 4.2 23.0 ± 4.2 n.s 22.8 ± 3.6 22.3 ± 3.7 0.01 
Hb (g/L) 105 ± 8 109 ± 9 0.001 105 ± 7 115 ± 9 0.001 
Hct (%) 36.0 ± 2.5 36.1 ± 2.6 0.788 36.5 ± 2,4 38.1 ± 2.7 0.002 
MCV (fl) 88.2 ± 7.2 88.6 ± 6.7 0.443 89.0 ± 5.8 90.3 ± 5.4 0.189 
MCH (pg) 25.7 ± 2.7 27.0 ± 2.2 0.001 25.8 ± 2.2 27.5 ± 1.9 0.001 
Ferritin1 
(µg/L) 
1.2 ± 0.4 1.2 ± 0.4 0.601 1.1 ± 0.4 1.4 ± 0.3 0.001 
AGP (g/L) 0.7 ± 1.2 0.8 ± 0.4 0.809 0.7 ± 0.2 0.8 ± 0.2 0.209 
2CRP 3 3  2 3  
 
BMI: Body Mass Index; Hb: Haemoglobin; Hct: Hematocrit; MCV: Mean Corpuscular 
Volume;  
 
MCH: Mean Corpuscular Haemoglobin; AGP: α-1 acid glycoprotein; CRP: C-reactive protein 
Mean ± SD; n = number of subjects 
 
1Log concentration of ferritin 
2Number of subjects who had CRP value > 5 mg/l 
3Comparison of variables in paired samples, from baseline to the end of study (3 mo), was 
done with Wilcoxon test. 
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